ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“The latest Impact Factors highlight the growing influence of ESMO’s journal portfolio:
- Annals of Oncology has achieved a record Impact Factor of 80.4, up from 65.4, further reinforcing its position among the world’s leading oncology journals.
- ESMO Open has reached an Impact Factor of 10.6, reflecting its continued growth as a publication for clinically relevant and practice-changing research.
- Both ESMO Gastrointestinal Oncology and ESMO Real World Data and Digital Oncology have received their first-ever Impact Factors, marking important milestones in their development.
Together, these results reflect the quality, relevance, and scientific impact of the research published across ESMO Journals, supporting knowledge dissemination, fostering scientific exchange, and contributing to advances in cancer care worldwide.
Read the full news here.”
Other articles about ESMO on OncoDaily.
